1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Digital Companion Diagnostics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Polymerase Chain Reaction (PCR) 1.2.3 Immunohistochemistry (IHC) 1.2.4 In Situ Hybridization (ISH) 1.2.5 Next Generation Sequencing (NGS) 1.3 Market by Application 1.3.1 Global Digital Companion Diagnostics Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospitals 1.3.3 Pharmaceutical Companies 1.3.4 Laboratories 1.3.5 Other 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Digital Companion Diagnostics Market Perspective (2016-2027) 2.2 Digital Companion Diagnostics Growth Trends by Regions 2.2.1 Digital Companion Diagnostics Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Digital Companion Diagnostics Historic Market Share by Regions (2016-2021) 2.2.3 Digital Companion Diagnostics Forecasted Market Size by Regions (2022-2027) 2.3 Digital Companion Diagnostics Industry Dynamic 2.3.1 Digital Companion Diagnostics Market Trends 2.3.2 Digital Companion Diagnostics Market Drivers 2.3.3 Digital Companion Diagnostics Market Challenges 2.3.4 Digital Companion Diagnostics Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Digital Companion Diagnostics Players by Revenue 3.1.1 Global Top Digital Companion Diagnostics Players by Revenue (2016-2021) 3.1.2 Global Digital Companion Diagnostics Revenue Market Share by Players (2016-2021) 3.2 Global Digital Companion Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Digital Companion Diagnostics Revenue 3.4 Global Digital Companion Diagnostics Market Concentration Ratio 3.4.1 Global Digital Companion Diagnostics Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Digital Companion Diagnostics Revenue in 2020 3.5 Digital Companion Diagnostics Key Players Head office and Area Served 3.6 Key Players Digital Companion Diagnostics Product Solution and Service 3.7 Date of Enter into Digital Companion Diagnostics Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Digital Companion Diagnostics Breakdown Data by Type 4.1 Global Digital Companion Diagnostics Historic Market Size by Type (2016-2021) 4.2 Global Digital Companion Diagnostics Forecasted Market Size by Type (2022-2027) 5 Digital Companion Diagnostics Breakdown Data by Application 5.1 Global Digital Companion Diagnostics Historic Market Size by Application (2016-2021) 5.2 Global Digital Companion Diagnostics Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Digital Companion Diagnostics Market Size (2016-2027) 6.2 North America Digital Companion Diagnostics Market Size by Type 6.2.1 North America Digital Companion Diagnostics Market Size by Type (2016-2021) 6.2.2 North America Digital Companion Diagnostics Market Size by Type (2022-2027) 6.2.3 North America Digital Companion Diagnostics Market Size by Type (2016-2027) 6.3 North America Digital Companion Diagnostics Market Size by Application 6.3.1 North America Digital Companion Diagnostics Market Size by Application (2016-2021) 6.3.2 North America Digital Companion Diagnostics Market Size by Application (2022-2027) 6.3.3 North America Digital Companion Diagnostics Market Size by Application (2016-2027) 6.4 North America Digital Companion Diagnostics Market Size by Country 6.4.1 North America Digital Companion Diagnostics Market Size by Country (2016-2021) 6.4.2 North America Digital Companion Diagnostics Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Digital Companion Diagnostics Market Size (2016-2027) 7.2 Europe Digital Companion Diagnostics Market Size by Type 7.2.1 Europe Digital Companion Diagnostics Market Size by Type (2016-2021) 7.2.2 Europe Digital Companion Diagnostics Market Size by Type (2022-2027) 7.2.3 Europe Digital Companion Diagnostics Market Size by Type (2016-2027) 7.3 Europe Digital Companion Diagnostics Market Size by Application 7.3.1 Europe Digital Companion Diagnostics Market Size by Application (2016-2021) 7.3.2 Europe Digital Companion Diagnostics Market Size by Application (2022-2027) 7.3.3 Europe Digital Companion Diagnostics Market Size by Application (2016-2027) 7.4 Europe Digital Companion Diagnostics Market Size by Country 7.4.1 Europe Digital Companion Diagnostics Market Size by Country (2016-2021) 7.4.2 Europe Digital Companion Diagnostics Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Digital Companion Diagnostics Market Size (2016-2027) 8.2 Asia-Pacific Digital Companion Diagnostics Market Size by Type 8.2.1 Asia-Pacific Digital Companion Diagnostics Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Digital Companion Diagnostics Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Digital Companion Diagnostics Market Size by Type (2016-2027) 8.3 Asia-Pacific Digital Companion Diagnostics Market Size by Application 8.3.1 Asia-Pacific Digital Companion Diagnostics Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Digital Companion Diagnostics Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Digital Companion Diagnostics Market Size by Application (2016-2027) 8.4 Asia-Pacific Digital Companion Diagnostics Market Size by Region 8.4.1 Asia-Pacific Digital Companion Diagnostics Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Digital Companion Diagnostics Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Digital Companion Diagnostics Market Size (2016-2027) 9.2 Latin America Digital Companion Diagnostics Market Size by Type 9.2.1 Latin America Digital Companion Diagnostics Market Size by Type (2016-2021) 9.2.2 Latin America Digital Companion Diagnostics Market Size by Type (2022-2027) 9.2.3 Latin America Digital Companion Diagnostics Market Size by Type (2016-2027) 9.3 Latin America Digital Companion Diagnostics Market Size by Application 9.3.1 Latin America Digital Companion Diagnostics Market Size by Application (2016-2021) 9.3.2 Latin America Digital Companion Diagnostics Market Size by Application (2022-2027) 9.3.3 Latin America Digital Companion Diagnostics Market Size by Application (2016-2027) 9.4 Latin America Digital Companion Diagnostics Market Size by Country 9.4.1 Latin America Digital Companion Diagnostics Market Size by Country (2016-2021) 9.4.2 Latin America Digital Companion Diagnostics Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Digital Companion Diagnostics Market Size (2016-2027) 10.2 Middle East & Africa Digital Companion Diagnostics Market Size by Type 10.2.1 Middle East & Africa Digital Companion Diagnostics Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Digital Companion Diagnostics Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Digital Companion Diagnostics Market Size by Type (2016-2027) 10.3 Middle East & Africa Digital Companion Diagnostics Market Size by Application 10.3.1 Middle East & Africa Digital Companion Diagnostics Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Digital Companion Diagnostics Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Digital Companion Diagnostics Market Size by Application (2016-2027) 10.4 Middle East & Africa Digital Companion Diagnostics Market Size by Country 10.4.1 Middle East & Africa Digital Companion Diagnostics Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Digital Companion Diagnostics Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Roche Holdings (Switzerland) 11.1.1 Roche Holdings (Switzerland) Company Details 11.1.2 Roche Holdings (Switzerland) Business Overview 11.1.3 Roche Holdings (Switzerland) Digital Companion Diagnostics Introduction 11.1.4 Roche Holdings (Switzerland) Revenue in Digital Companion Diagnostics Business (2016-2021) 11.1.5 Roche Holdings (Switzerland) Recent Development 11.2 Abbott Laboratories (US) 11.2.1 Abbott Laboratories (US) Company Details 11.2.2 Abbott Laboratories (US) Business Overview 11.2.3 Abbott Laboratories (US) Digital Companion Diagnostics Introduction 11.2.4 Abbott Laboratories (US) Revenue in Digital Companion Diagnostics Business (2016-2021) 11.2.5 Abbott Laboratories (US) Recent Development 11.3 Thermo Fisher Scientific (US) 11.3.1 Thermo Fisher Scientific (US) Company Details 11.3.2 Thermo Fisher Scientific (US) Business Overview 11.3.3 Thermo Fisher Scientific (US) Digital Companion Diagnostics Introduction 11.3.4 Thermo Fisher Scientific (US) Revenue in Digital Companion Diagnostics Business (2016-2021) 11.3.5 Thermo Fisher Scientific (US) Recent Development 11.4 Agilent Technologies (US) 11.4.1 Agilent Technologies (US) Company Details 11.4.2 Agilent Technologies (US) Business Overview 11.4.3 Agilent Technologies (US) Digital Companion Diagnostics Introduction 11.4.4 Agilent Technologies (US) Revenue in Digital Companion Diagnostics Business (2016-2021) 11.4.5 Agilent Technologies (US) Recent Development 11.5 Life Technologies (US) 11.5.1 Life Technologies (US) Company Details 11.5.2 Life Technologies (US) Business Overview 11.5.3 Life Technologies (US) Digital Companion Diagnostics Introduction 11.5.4 Life Technologies (US) Revenue in Digital Companion Diagnostics Business (2016-2021) 11.5.5 Life Technologies (US) Recent Development 11.6 GE Healthcare (UK) 11.6.1 GE Healthcare (UK) Company Details 11.6.2 GE Healthcare (UK) Business Overview 11.6.3 GE Healthcare (UK) Digital Companion Diagnostics Introduction 11.6.4 GE Healthcare (UK) Revenue in Digital Companion Diagnostics Business (2016-2021) 11.6.5 GE Healthcare (UK) Recent Development 11.7 Agendia (Angola) 11.7.1 Agendia (Angola) Company Details 11.7.2 Agendia (Angola) Business Overview 11.7.3 Agendia (Angola) Digital Companion Diagnostics Introduction 11.7.4 Agendia (Angola) Revenue in Digital Companion Diagnostics Business (2016-2021) 11.7.5 Agendia (Angola) Recent Development 11.8 Qiagen (Germany) 11.8.1 Qiagen (Germany) Company Details 11.8.2 Qiagen (Germany) Business Overview 11.8.3 Qiagen (Germany) Digital Companion Diagnostics Introduction 11.8.4 Qiagen (Germany) Revenue in Digital Companion Diagnostics Business (2016-2021) 11.8.5 Qiagen (Germany) Recent Development 11.9 Genomic Health (US) 11.9.1 Genomic Health (US) Company Details 11.9.2 Genomic Health (US) Business Overview 11.9.3 Genomic Health (US) Digital Companion Diagnostics Introduction 11.9.4 Genomic Health (US) Revenue in Digital Companion Diagnostics Business (2016-2021) 11.9.5 Genomic Health (US) Recent Development 11.10 Myriad Genetics (US) 11.10.1 Myriad Genetics (US) Company Details 11.10.2 Myriad Genetics (US) Business Overview 11.10.3 Myriad Genetics (US) Digital Companion Diagnostics Introduction 11.10.4 Myriad Genetics (US) Revenue in Digital Companion Diagnostics Business (2016-2021) 11.10.5 Myriad Genetics (US) Recent Development 11.11 Advanced Cell Diagnostics (US) 11.11.1 Advanced Cell Diagnostics (US) Company Details 11.11.2 Advanced Cell Diagnostics (US) Business Overview 11.11.3 Advanced Cell Diagnostics (US) Digital Companion Diagnostics Introduction 11.11.4 Advanced Cell Diagnostics (US) Revenue in Digital Companion Diagnostics Business (2016-2021) 11.11.5 Advanced Cell Diagnostics (US) Recent Development 11.12 Danaher (US) 11.12.1 Danaher (US) Company Details 11.12.2 Danaher (US) Business Overview 11.12.3 Danaher (US) Digital Companion Diagnostics Introduction 11.12.4 Danaher (US) Revenue in Digital Companion Diagnostics Business (2016-2021) 11.12.5 Danaher (US) Recent Development 11.13 Applied Proteomics (US) 11.13.1 Applied Proteomics (US) Company Details 11.13.2 Applied Proteomics (US) Business Overview 11.13.3 Applied Proteomics (US) Digital Companion Diagnostics Introduction 11.13.4 Applied Proteomics (US) Revenue in Digital Companion Diagnostics Business (2016-2021) 11.13.5 Applied Proteomics (US) Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Digital Companion Diagnostics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Polymerase Chain Reaction (PCR) Table 3. Key Players of Immunohistochemistry (IHC) Table 4. Key Players of In Situ Hybridization (ISH) Table 5. Key Players of Next Generation Sequencing (NGS) Table 6. Global Digital Companion Diagnostics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Digital Companion Diagnostics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global Digital Companion Diagnostics Market Size by Regions (2016-2021) & (US$ Million) Table 9. Global Digital Companion Diagnostics Market Share by Regions (2016-2021) Table 10. Global Digital Companion Diagnostics Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 11. Global Digital Companion Diagnostics Market Share by Regions (2022-2027) Table 12. Digital Companion Diagnostics Market Trends Table 13. Digital Companion Diagnostics Market Drivers Table 14. Digital Companion Diagnostics Market Challenges Table 15. Digital Companion Diagnostics Market Restraints Table 16. Global Digital Companion Diagnostics Revenue by Players (2016-2021) & (US$ Million) Table 17. Global Digital Companion Diagnostics Market Share by Players (2016-2021) Table 18. Global Top Digital Companion Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Digital Companion Diagnostics as of 2020) Table 19. Ranking of Global Top Digital Companion Diagnostics Companies by Revenue (US$ Million) in 2020 Table 20. Global 5 Largest Players Market Share by Digital Companion Diagnostics Revenue (CR5 and HHI) & (2016-2021) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Digital Companion Diagnostics Product Solution and Service Table 23. Date of Enter into Digital Companion Diagnostics Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Digital Companion Diagnostics Market Size by Type (2016-2021) (US$ Million) Table 26. Global Digital Companion Diagnostics Revenue Market Share by Type (2016-2021) Table 27. Global Digital Companion Diagnostics Forecasted Market Size by Type (2022-2027) (US$ Million) Table 28. Global Digital Companion Diagnostics Revenue Market Share by Type (2022-2027) & (US$ Million) Table 29. Global Digital Companion Diagnostics Market Size Share by Application (2016-2021) & (US$ Million) Table 30. Global Digital Companion Diagnostics Revenue Market Share by Application (2016-2021) Table 31. Global Digital Companion Diagnostics Forecasted Market Size by Application (2022-2027) (US$ Million) Table 32. Global Digital Companion Diagnostics Revenue Market Share by Application (2022-2027) & (US$ Million) Table 33. North America Digital Companion Diagnostics Market Size by Type (2016-2021) (US$ Million) Table 34. North America Digital Companion Diagnostics Market Size by Type (2022-2027) & (US$ Million) Table 35. North America Digital Companion Diagnostics Market Size by Application (2016-2021) (US$ Million) Table 36. North America Digital Companion Diagnostics Market Size by Application (2022-2027) & (US$ Million) Table 37. North America Digital Companion Diagnostics Market Size by Country (2016-2021) & (US$ Million) Table 38. North America Digital Companion Diagnostics Market Size by Country (2022-2027) & (US$ Million) Table 39. Europe Digital Companion Diagnostics Market Size by Type (2016-2021) (US$ Million) Table 40. Europe Digital Companion Diagnostics Market Size by Type (2022-2027) & (US$ Million) Table 41. Europe Digital Companion Diagnostics Market Size by Application (2016-2021) (US$ Million) Table 42. Europe Digital Companion Diagnostics Market Size by Application (2022-2027) & (US$ Million) Table 43. Europe Digital Companion Diagnostics Market Size by Country (2016-2021) & (US$ Million) Table 44. Europe Digital Companion Diagnostics Market Size by Country (2022-2027) & (US$ Million) Table 45. Asia-Pacific Digital Companion Diagnostics Market Size by Type (2016-2021) (US$ Million) Table 46. Asia-Pacific Digital Companion Diagnostics Market Size by Type (2022-2027) & (US$ Million) Table 47. Asia-Pacific Digital Companion Diagnostics Market Size by Application (2016-2021) (US$ Million) Table 48. Asia-Pacific Digital Companion Diagnostics Market Size by Application (2022-2027) & (US$ Million) Table 49. Asia-Pacific Digital Companion Diagnostics Market Size by Region (2016-2021) & (US$ Million) Table 50. Asia-Pacific Digital Companion Diagnostics Market Size by Region (2022-2027) & (US$ Million) Table 51. Latin America Digital Companion Diagnostics Market Size by Type (2016-2021) (US$ Million) Table 52. Latin America Digital Companion Diagnostics Market Size by Type (2022-2027) & (US$ Million) Table 53. Latin America Digital Companion Diagnostics Market Size by Application (2016-2021) (US$ Million) Table 54. Latin America Digital Companion Diagnostics Market Size by Application (2022-2027) & (US$ Million) Table 55. Latin America Digital Companion Diagnostics Market Size by Country (2016-2021) & (US$ Million) Table 56. Latin America Digital Companion Diagnostics Market Size by Country (2022-2027) & (US$ Million) Table 57. Middle East & Africa Digital Companion Diagnostics Market Size by Type (2016-2021) (US$ Million) Table 58. Middle East & Africa Digital Companion Diagnostics Market Size by Type (2022-2027) & (US$ Million) Table 59. Middle East & Africa Digital Companion Diagnostics Market Size by Application (2016-2021) (US$ Million) Table 60. Middle East & Africa Digital Companion Diagnostics Market Size by Application (2022-2027) & (US$ Million) Table 61. Middle East & Africa Digital Companion Diagnostics Market Size by Country (2016-2021) & (US$ Million) Table 62. Middle East & Africa Digital Companion Diagnostics Market Size by Country (2022-2027) & (US$ Million) Table 63. Roche Holdings (Switzerland) Company Details Table 64. Roche Holdings (Switzerland) Business Overview Table 65. Roche Holdings (Switzerland) Digital Companion Diagnostics Product Table 66. Roche Holdings (Switzerland) Revenue in Digital Companion Diagnostics Business (2016-2021) & (US$ Million) Table 67. Roche Holdings (Switzerland) Recent Development Table 68. Abbott Laboratories (US) Company Details Table 69. Abbott Laboratories (US) Business Overview Table 70. Abbott Laboratories (US) Digital Companion Diagnostics Product Table 71. Abbott Laboratories (US) Revenue in Digital Companion Diagnostics Business (2016-2021) & (US$ Million) Table 72. Abbott Laboratories (US) Recent Development Table 73. Thermo Fisher Scientific (US) Company Details Table 74. Thermo Fisher Scientific (US) Business Overview Table 75. Thermo Fisher Scientific (US) Digital Companion Diagnostics Product Table 76. Thermo Fisher Scientific (US) Revenue in Digital Companion Diagnostics Business (2016-2021) & (US$ Million) Table 77. Thermo Fisher Scientific (US) Recent Development Table 78. Agilent Technologies (US) Company Details Table 79. Agilent Technologies (US) Business Overview Table 80. Agilent Technologies (US) Digital Companion Diagnostics Product Table 81. Agilent Technologies (US) Revenue in Digital Companion Diagnostics Business (2016-2021) & (US$ Million) Table 82. Agilent Technologies (US) Recent Development Table 83. Life Technologies (US) Company Details Table 84. Life Technologies (US) Business Overview Table 85. Life Technologies (US) Digital Companion Diagnostics Product Table 86. Life Technologies (US) Revenue in Digital Companion Diagnostics Business (2016-2021) & (US$ Million) Table 87. Life Technologies (US) Recent Development Table 88. GE Healthcare (UK) Company Details Table 89. GE Healthcare (UK) Business Overview Table 90. GE Healthcare (UK) Digital Companion Diagnostics Product Table 91. GE Healthcare (UK) Revenue in Digital Companion Diagnostics Business (2016-2021) & (US$ Million) Table 92. GE Healthcare (UK) Recent Development Table 93. Agendia (Angola) Company Details Table 94. Agendia (Angola) Business Overview Table 95. Agendia (Angola) Digital Companion Diagnostics Product Table 96. Agendia (Angola) Revenue in Digital Companion Diagnostics Business (2016-2021) & (US$ Million) Table 97. Agendia (Angola) Recent Development Table 98. Qiagen (Germany) Company Details Table 99. Qiagen (Germany) Business Overview Table 100. Qiagen (Germany) Revenue in Digital Companion Diagnostics Business (2016-2021) & (US$ Million) Table 101. Qiagen (Germany) Recent Development Table 102. Genomic Health (US) Company Details Table 103. Genomic Health (US) Business Overview Table 104. Genomic Health (US) Digital Companion Diagnostics Product Table 105. Genomic Health (US) Revenue in Digital Companion Diagnostics Business (2016-2021) & (US$ Million) Table 106. Genomic Health (US) Recent Development Table 107. Myriad Genetics (US) Company Details Table 108. Myriad Genetics (US) Business Overview Table 109. Myriad Genetics (US) Digital Companion Diagnostics Product Table 110. Myriad Genetics (US) Revenue in Digital Companion Diagnostics Business (2016-2021) & (US$ Million) Table 111. Myriad Genetics (US) Recent Development Table 112. Advanced Cell Diagnostics (US) Company Details Table 113. Advanced Cell Diagnostics (US) Business Overview Table 114. Advanced Cell Diagnostics (US) Digital Companion Diagnostics Product Table 115. Advanced Cell Diagnostics (US) Revenue in Digital Companion Diagnostics Business (2016-2021) & (US$ Million) Table 116. Advanced Cell Diagnostics (US) Recent Development Table 117. Danaher (US) Company Details Table 118. Danaher (US) Business Overview Table 119. Danaher (US) Digital Companion Diagnostics Product Table 120. Danaher (US) Revenue in Digital Companion Diagnostics Business (2016-2021) & (US$ Million) Table 121. Danaher (US) Recent Development Table 122. Applied Proteomics (US) Company Details Table 123. Applied Proteomics (US) Business Overview Table 124. Applied Proteomics (US) Digital Companion Diagnostics Product Table 125. Applied Proteomics (US) Revenue in Digital Companion Diagnostics Business (2016-2021) & (US$ Million) Table 126. Applied Proteomics (US) Recent Development Table 127. Research Programs/Design for This Report Table 128. Key Data Information from Secondary Sources Table 129. Key Data Information from Primary Sources List of Figures Figure 1. Global Digital Companion Diagnostics Market Share by Type: 2020 VS 2027 Figure 2. Polymerase Chain Reaction (PCR) Features Figure 3. Immunohistochemistry (IHC) Features Figure 4. In Situ Hybridization (ISH) Features Figure 5. Next Generation Sequencing (NGS) Features Figure 6. Global Digital Companion Diagnostics Market Share by Application: 2020 VS 2027 Figure 7. Hospitals Case Studies Figure 8. Pharmaceutical Companies Case Studies Figure 9. Laboratories Case Studies Figure 10. Other Case Studies Figure 11. Digital Companion Diagnostics Report Years Considered Figure 12. Global Digital Companion Diagnostics Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 13. Global Digital Companion Diagnostics Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 14. Global Digital Companion Diagnostics Market Share by Regions: 2020 VS 2027 Figure 15. Global Digital Companion Diagnostics Market Share by Regions (2022-2027) Figure 16. Global Digital Companion Diagnostics Market Share by Players in 2020 Figure 17. Global Top Digital Companion Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Digital Companion Diagnostics as of 2020 Figure 18. The Top 10 and 5 Players Market Share by Digital Companion Diagnostics Revenue in 2020 Figure 19. Global Digital Companion Diagnostics Revenue Market Share by Type (2016-2021) Figure 20. Global Digital Companion Diagnostics Revenue Market Share by Type (2022-2027) Figure 21. North America Digital Companion Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 22. North America Digital Companion Diagnostics Market Share by Type (2016-2027) Figure 23. North America Digital Companion Diagnostics Market Share by Application (2016-2027) Figure 24. North America Digital Companion Diagnostics Market Share by Country (2016-2027) Figure 25. United States Digital Companion Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Canada Digital Companion Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Europe Digital Companion Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 28. Europe Digital Companion Diagnostics Market Share by Type (2016-2027) Figure 29. Europe Digital Companion Diagnostics Market Share by Application (2016-2027) Figure 30. Europe Digital Companion Diagnostics Market Share by Country (2016-2027) Figure 31. Germany Digital Companion Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. France Digital Companion Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. U.K. Digital Companion Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Italy Digital Companion Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Russia Digital Companion Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Nordic Digital Companion Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Asia-Pacific Digital Companion Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Asia-Pacific Digital Companion Diagnostics Market Share by Type (2016-2027) Figure 39. Asia-Pacific Digital Companion Diagnostics Market Share by Application (2016-2027) Figure 40. Asia-Pacific Digital Companion Diagnostics Market Share by Region (2016-2027) Figure 41. China Digital Companion Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Japan Digital Companion Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. South Korea Digital Companion Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Southeast Asia Digital Companion Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. India Digital Companion Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Australia Digital Companion Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Latin America Digital Companion Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Latin America Digital Companion Diagnostics Market Share by Type (2016-2027) Figure 49. Latin America Digital Companion Diagnostics Market Share by Application (2016-2027) Figure 50. Latin America Digital Companion Diagnostics Market Share by Country (2016-2027) Figure 51. Mexico Digital Companion Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Brazil Digital Companion Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Middle East & Africa Digital Companion Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 54. Middle East & Africa Digital Companion Diagnostics Market Share by Type (2016-2027) Figure 55. Middle East & Africa Digital Companion Diagnostics Market Share by Application (2016-2027) Figure 56. Middle East & Africa Digital Companion Diagnostics Market Share by Country (2016-2027) Figure 57. Turkey Digital Companion Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Saudi Arabia Digital Companion Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. UAE Digital Companion Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 60. Roche Holdings (Switzerland) Revenue Growth Rate in Digital Companion Diagnostics Business (2016-2021) Figure 61. Abbott Laboratories (US) Revenue Growth Rate in Digital Companion Diagnostics Business (2016-2021) Figure 62. Thermo Fisher Scientific (US) Revenue Growth Rate in Digital Companion Diagnostics Business (2016-2021) Figure 63. Agilent Technologies (US) Revenue Growth Rate in Digital Companion Diagnostics Business (2016-2021) Figure 64. Life Technologies (US) Revenue Growth Rate in Digital Companion Diagnostics Business (2016-2021) Figure 65. GE Healthcare (UK) Revenue Growth Rate in Digital Companion Diagnostics Business (2016-2021) Figure 66. Agendia (Angola) Revenue Growth Rate in Digital Companion Diagnostics Business (2016-2021) Figure 67. Qiagen (Germany) Revenue Growth Rate in Digital Companion Diagnostics Business (2016-2021) Figure 68. Genomic Health (US) Revenue Growth Rate in Digital Companion Diagnostics Business (2016-2021) Figure 69. Myriad Genetics (US) Revenue Growth Rate in Digital Companion Diagnostics Business (2016-2021) Figure 70. Advanced Cell Diagnostics (US) Revenue Growth Rate in Digital Companion Diagnostics Business (2016-2021) Figure 71. Danaher (US) Revenue Growth Rate in Digital Companion Diagnostics Business (2016-2021) Figure 72. Applied Proteomics (US) Revenue Growth Rate in Digital Companion Diagnostics Business (2016-2021) Figure 73. Bottom-up and Top-down Approaches for This Report Figure 74. Data Triangulation Figure 75. Key Executives Interviewed

Roche Holdings (Switzerland) Abbott Laboratories (US) Thermo Fisher Scientific (US) Agilent Technologies (US) Life Technologies (US) GE Healthcare (UK) Agendia (Angola) Qiagen (Germany) Genomic Health (US) Myriad Genetics (US) Advanced Cell Diagnostics (US) Danaher (US) Applied Proteomics (US)